Related Experiment Videos
Cerebral toxoplasmosis in patients with AIDS
E Rossitch1, E J Carrazana, M A Samuels
1Brigham and Women's Hospital, Boston, Massachusetts.
American Family Physician
|March 1, 1990
Summary
Central nervous system infections from Toxoplasma gondii are increasingly common in AIDS patients. Early diagnosis and antitoxoplasma therapy are crucial for managing cerebral toxoplasmosis in this population.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Neurology
Background:
- Toxoplasma gondii is an opportunistic pathogen.
- Central nervous system (CNS) infections are a significant concern in individuals with acquired immunodeficiency syndrome (AIDS).
- Cerebral toxoplasmosis has emerged as a leading cause of CNS disease in AIDS patients.
Purpose of the Study:
- To highlight the importance of considering cerebral toxoplasmosis in the differential diagnosis of neurologic conditions in AIDS patients.
- To outline diagnostic and therapeutic strategies for cerebral toxoplasmosis in the context of AIDS.
Main Methods:
- Clinical observation and case review.
- Diagnostic criteria including serology and neuroimaging (computed tomographic scans).
- Treatment protocols involving antitoxoplasma therapy and considerations for biopsy.
Main Results:
- Neurologic signs and symptoms in AIDS patients warrant consideration for cerebral toxoplasmosis.
- Positive serology and characteristic CT lesions suggest the need for empirical antitoxoplasma therapy.
- Atypical presentations or lack of response may necessitate further investigation, including biopsy.
Conclusions:
- Cerebral toxoplasmosis is a critical diagnosis in immunocompromised individuals with AIDS presenting with neurological deficits.
- Prompt initiation of antitoxoplasma therapy is recommended for patients with confirmed or highly suspected cerebral toxoplasmosis.
- Biopsy remains an important diagnostic tool for refractory or atypical cases, aiding in definitive diagnosis and guiding treatment adjustments.